Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
Not Applicable
Completed
- Conditions
- Toxoplasmosis, CerebralHIV Infections
- Registration Number
- NCT00002064
- Lead Sponsor
- Palo Alto Medical Foundation
- Brief Summary
To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Palo Alto Med Foundation
🇺🇸Palo Alto, California, United States
Palo Alto Med Foundation🇺🇸Palo Alto, California, United States